To date, a screen of the collection of FDA - approved drugs in the Prestwick Library has identified a handful of potential candidates which have demonstrated
effectiveness at lowering secretion of IL - 6, a component of SASP whose
concentration tends to rise systemically with aging and here used as a preliminary marker of SASP as a phenotype.